The German Biobank Alliance (GBA) has elected a new 12-member Steering Committee (SC) for the period 2024–2025. The SC regularly discusses the concerns of the network and makes decisions on its further development. The following candidates were elected by the GBA's partner and observer biobanks:
- Dr. Heidi Altmann (Dresden Integrated Liquid Biobank of the BioBank Dresden)
- Dr. Gabriele Anton (Central Biobank of the University of Bielefeld)
- Dr. Ronny Baber (Leipzig Medical Biobank),
- Dr. Daniel Brucker (Interdisciplinary Biomaterial Bank and Database Frankfurt),
- Prof. Dr. Thomas Illig (Hannover Unified Biobank),
- Prof. Dr. Roland Jahns (Interdisciplinary Biomaterial Bank and Database Würzburg),
- PD Dr. Michael Kiehntopf (Integrated Biobank Jena),
- Dr. Romy Kirsten (Integrated Biobank Mannheim),
- Prof. Dr. Martin Lablans (German Cancer Research Center Heidelberg),
- Prof. Dr. Alexandra Nieters (Freeze Biobank Freiburg),
- PD Dr. Sara Nußbeck (Central Biobank UMG, Göttingen)
- and Dr. Alexandra Stege (Central Biobank Charité/BIH, Berlin).
In addition to the 12 elected members of the SC, Prof. Dr. Michael Hummel (current National Node Director) will attend the SC meetings as a permanent guest in an advisory capacity. In the first quarter of 2024, the 12 members will elect an Executive Board from among themselves. This Board will consist of three people – a newly elected spokesperson (National Node Director) and two deputies.
More information:
